A Phase 1 Study of HB2198 in Participants With Moderately to Severely Active Systemic Lupus Erythematosus (SLE)

Clinical trial NCT07491900 · RECRUITING

Trial details

NCT number: NCT07491900
Sponsor: Hinge Bio
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Systemic Lupus Erthematosus (SLE)Lupus Nephritis (LN)Extra-renal Lupus (ERL)

Start date: 2026-03-23
Primary completion: 2027-10-24
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.